Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/15103
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Van Ginderachter, Laura | - |
dc.contributor.author | Cox, Tony | - |
dc.contributor.author | Drijkoningen, Ria | - |
dc.contributor.author | ACHTEN, Ruth | - |
dc.contributor.author | Joosens, Eric | - |
dc.contributor.author | Maes, Annelies | - |
dc.contributor.author | Theunissen, Koen | - |
dc.contributor.author | MEBIS, Jeroen | - |
dc.date.accessioned | 2013-04-24T12:21:28Z | - |
dc.date.available | 2013-04-24T12:21:28Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Case Report Oncology, 6, p. 45-49 | - |
dc.identifier.issn | 1662-6575 | - |
dc.identifier.uri | http://hdl.handle.net/1942/15103 | - |
dc.description.abstract | Temozolomide (TMZ) is an alkylating agent, used for the treatment of high-grade gliomas. This case report describes the development of a non-Hodgkin lymphoma in a patient treated with extended-dose temozolomide and radiotherapy. In addition to the possible mutagenic effect of temozolomide – as described for all alkylating agents – there might have been an immunosuppressive effect of TMZ. The pathological appearance of the lymphoma as well as the presence of a grade 3 lymphopenia early in treatment supports this hypothesis. As the use of TMZ increases, the awareness that TMZ may induce secondary malignancies should increase as well. | - |
dc.language.iso | en | - |
dc.title | Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case report | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 49 | - |
dc.identifier.spage | 45 | - |
dc.identifier.volume | 6 | - |
local.bibliographicCitation.jcat | A2 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1159/000346614 | - |
item.accessRights | Closed Access | - |
item.contributor | Van Ginderachter, Laura | - |
item.contributor | Cox, Tony | - |
item.contributor | Drijkoningen, Ria | - |
item.contributor | ACHTEN, Ruth | - |
item.contributor | Joosens, Eric | - |
item.contributor | Maes, Annelies | - |
item.contributor | Theunissen, Koen | - |
item.contributor | MEBIS, Jeroen | - |
item.fullcitation | Van Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen & MEBIS, Jeroen (2013) Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case report. In: Case Report Oncology, 6, p. 45-49. | - |
item.fulltext | No Fulltext | - |
crisitem.journal.issn | 1662-6575 | - |
crisitem.journal.eissn | 1662-6575 | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.